Ligand validation:7P07

MB3: 1-methylpyrrolidin-2-one

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7P07_MB3_B_602	17%	10%	0.265	0.845	2.37	1.93	4	3	0	0	100%	1
7P07_MB3_A_602	5%	22%	0.285	0.692	2.39	0.9	4	-	0	0	100%	1
7P01_MB3_B_701	42%	10%	0.191	0.911	2.26	2.04	4	3	0	0	100%	1
4QSS_MB3_A_1207	98%	43%	0.06	0.986	1.24	0.98	1	-	0	0	100%	1
5XDT_MB3_A_404	92%	88%	0.073	0.964	0.15	0.52	-	-	0	0	100%	1
6YD6_MB3_A_404	87%	46%	0.071	0.941	1.16	0.95	1	-	0	0	100%	1
3MB4_MB3_B_1	87%	63%	0.083	0.953	0.86	0.57	-	-	0	0	100%	1
3P1D_MB3_A_1198	77%	68%	0.12	0.961	0.4	0.83	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.